|
⚲
|
| Keyboard |
| Tenbarge Bryce
✚
|
|
|---|---|
| CIK # | 0001682907 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001682907] | |
| 4 | [0001682907] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tenbarge Bryce | |
| Progenics Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 82,214 | ||
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 75,900 | ||
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 66,000 | ||
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 75,000 | ||
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 90,750 | ||
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2020-03-02 | Grant | 82,214 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2019-03-01 | Grant | 90,750 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2018-03-01 | Grant | 75,900 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2017-03-01 | Grant | 66,000 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2016-10-03 | Grant | 75,000 | $0.00 |